The Difference Between a Biosimilar and a Generic — What Hospital Pharmacists Need to Know
In hospital pharmacy conversations across India, two words get used interchangeably more often than they should: generic and biosimilar. Both refer to non-originator versions of existing medicines. Both are generally less expensive than the originator product. And both require regulatory approval before they can be sold. But beyond those surface similarities, the two are fundamentally […]
Sybrava (Neratinib) for HER2+ Breast Cancer in India — What Hospitals Need to Know
Among the medicines on A.K. Pharma’s product range that generate significant Google search traffic but relatively few clicks, Sybrava stands out. Over 2,000 impressions per month at position 5 — meaning it appears on the first page of Google for thousands of searches — but a click-through rate of under 1%. That gap between visibility […]
Zoladex 3.6mg vs 10.8mg — Which Formulation Is Right for Your Patient?
It is one of the most common procurement questions that hospital pharmacists and oncology nurses encounter when a patient is first prescribed Zoladex: which one do we order — the 3.6mg or the 10.8mg? The question sounds simple. The answer requires understanding not just the difference in dose and interval but also which indications each […]
Ozempic for Weight Loss in Delhi — What You Need to Know Before Asking Your Doctor
Ozempic has become one of the most searched medicine names in India over the past two years. That search volume is not coming from people with diabetes — although Ozempic is a diabetes medicine and that is what it is approved for. It is coming from people who have read about dramatic weight loss results […]
Does Hormone Therapy Cure Prostate Cancer? What Zoladex Actually Does — and Does Not Do
When a urologist or oncologist recommends Zoladex for prostate cancer, the word that tends to echo in the patient’s mind — and in the minds of their family — is the word they did not hear. The doctor explained what Zoladex does. They explained how it works, what to expect, what the side effects might […]
Why Some Medicines Are Imported Instead of Manufactured in India
Walk into any oncology department at a major Indian hospital and you will find medicines from Germany, the United States, Switzerland, Japan, and the United Kingdom sitting alongside domestically manufactured generics. For most patients and their families, this raises a perfectly reasonable question: why is this medicine coming from abroad? Why isn’t it made here? […]
India’s First Alzheimer’s Disease-Modifying Therapy Is Now Available — What It Means for Patients and Hospitals
For decades, treating Alzheimer’s disease in India meant managing symptoms. Medications like rivastigmine and donepezil could slow cognitive decline for a period, but nothing available in the Indian market could actually target the disease process itself — the accumulating amyloid plaques in the brain that are understood to drive the neurodegeneration underlying Alzheimer’s. That changed […]
How to Verify That Your Imported Cancer Medicine Is Genuine — A Safety Guide for Hospital Pharmacists in India 2026
In May 2026, Delhi Police busted a counterfeit medicine racket worth nearly Rs 10 crore — four people arrested for manufacturing and supplying fake life-saving drugs for cancer and liver disease. Fake medicines, packaging equipment, forged labels — all recovered from an operation supplying hospitals across multiple states. Weeks earlier in April 2026, a detailed […]
Ozempic vs Mounjaro vs Wegovy in India 2026 — Which GLP-1 Should Your Patient Choose?
India’s diabetes and obesity treatment landscape changed dramatically in March 2026. Novo Nordisk’s core Indian patent for semaglutide expired on March 20, 2026 — within hours, a wave of Indian pharmaceutical companies launched their own versions at dramatically lower prices. Branded Ozempic costs ₹8,800–₹11,175 per month in India, while the cheapest generic is now available […]